Article
Distinct immune-effector and metabolic profile of CD8<sup>+</sup> T Cells in patients with autoimmune polyarthritis induced by therapy with immune-checkpoint inhibitors
2022-03-12
Abstract excerpt
<h4>Objectives</h4> Rheumatic immune-related adverse events (irAE) such as (poly)arthritis in patients undergoing immune checkpoint inhibitor (ICI) treatment pose a major clinical challenge. ICI-therapy improves CD8+ T cell (CD8) function, but CD8 contribute to chronic inflammation in autoimmune arthritis (AA). Thus, we studied whether immune-functional and metabolic changes in CD8 explain the development of muscu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7d6a507-12c9-5fb0-be28-51ca8292e6b0
- DOI
- 10.1101/2022.03.09.22272158
